Altria recently published three new patent applications covering trichome and terpene production in cannabis and tobacco plants. Let's go over each in turn to
read more
Altria recently published three new patent applications covering trichome and terpene production in cannabis
read more
Tilray Earnings release July 28, 2022 and financials published later that day.
What I said last Q
Revenue might tell a story of consumers like a duck on
read more
Tilray Earnings release July 28, 2022 and financials published later that day.
What I said last Q
Reven
read more
Organigram released their earnings today.
What were our conclusions last Q??
Plus Side:
Sales increase $1.5 million +5% for fourth Q of increased reve
read more
Organigram released their earnings today.
What were our conclusions last Q??
Plus Side:
Sales increa
read more
Some news the other day about Fitch downgrading Canopy Growth's credit risk......landed on their equity with a dull 'thud', adding another layer of weight onto
read more
Some news the other day about Fitch downgrading Canopy Growth's credit risk......landed on their equity with
read more
Footer 1
Please scroll down until the end of this page to see the footer style
Recent Posts
Current State of Synbio Companies producing Cannabinoids
What’s really in Altria’s new Patent Applications?
Altria recently published three new patent applications covering trichome and terpene production in cannabis and tobacco plants. Let's go over each in turn to read more
Altria recently published three new patent applications covering trichome and terpene production in cannabis read more
Tilray Brands Q4 F2022 Rundown- May 31, 2022
Tilray Earnings release July 28, 2022 and financials published later that day. What I said last Q Revenue might tell a story of consumers like a duck on read more
Tilray Earnings release July 28, 2022 and financials published later that day. What I said last Q Reven read more
Tilray Rundown
Cannabis Administration and Opportunities Act – Filed July 21, 2022
Organigram Rundown Q3 F2022 May 31, 2022
Organigram released their earnings today. What were our conclusions last Q?? Plus Side: Sales increase $1.5 million +5% for fourth Q of increased reve read more
Organigram released their earnings today. What were our conclusions last Q?? Plus Side: Sales increa read more
Heritage Cannabis – Structure & Current State Q2 F2022
Some news the other day about Fitch downgrading Canopy Growth's credit risk......landed on their equity with a dull 'thud', adding another layer of weight onto read more
Some news the other day about Fitch downgrading Canopy Growth's credit risk......landed on their equity with read more
Legal Cannabis in North America: The Road Ahead